Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder

Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder

BackgroundSeveral studies have reported the efficacy and safety of rituximab (RTX) and mycophenolate mofetil (MMF) in neuromyelitis optica spectrum disorder (NMOSD). This study aimed to evaluate the efficacy and safety of long-term use of low-dose RTX and MMF in Chinese patients with NMOSD.MethodsWe...

Full description

Bibliographic Details
Main Authors: Jie Lin, Binbin Xue, Jia Li, Ruofan Zhu, Juyuan Pan, Zhibo Chen, Xu Zhang, Xiang Li, Junhui Xia
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Neurology
Subjects:
neuromyelitis optica spectrum disorder
rituximab
mycophenolate mofetil
EDSS
annual relapse rate
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.891064/full

Similar Items

Similar Items